» Articles » PMID: 21050134

P53, Oxidative Stress, and Aging

Overview
Specialty Endocrinology
Date 2010 Nov 6
PMID 21050134
Citations 145
Authors
Affiliations
Soon will be listed here.
Abstract

Mammalian aging is associated with elevated levels of oxidative damage of DNA, proteins, and lipids as a result of unbalanced prooxidant and antioxidant activities. Accumulating evidence indicates that oxidative stress is a major physiological inducer of aging. p53, the guardian of the genome that is important for cellular responses to oxidative stresses, might be a key coordinator of oxidative stress and aging. In response to low levels of oxidative stresses, p53 exhibits antioxidant activities to eliminate oxidative stress and ensure cell survival; in response to high levels of oxidative stresses, p53 exhibits pro-oxidative activities that further increase the levels of stresses, leading to cell death. p53 accomplishes these context-dependent roles by regulating the expression of a panel of genes involved in cellular responses to oxidative stresses and by modulating other pathways important for oxidative stress responses. The mechanism that switches p53 function from antioxidant to prooxidant remains unclear, but could account for the findings that increased p53 activities have been linked to both accelerated aging and increased life span in mice. Therefore, a balance of p53 antioxidant and prooxidant activities in response to oxidative stresses could be important for longevity by suppressing the accumulation of oxidative stresses and DNA damage.

Citing Articles

Cellular Senescence in Health, Disease, and Lens Aging.

Qin Y, Liu H, Wu H Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006057 PMC: 11859104. DOI: 10.3390/ph18020244.


New insights into methods to measure biological age: a literature review.

Mathur A, Taurin S, Alshammary S Front Aging. 2025; 5:1395649.

PMID: 39743988 PMC: 11688636. DOI: 10.3389/fragi.2024.1395649.


Age-related lung changes linked to altered lysosomal protease profile, histology, and ultrastructure.

Aufy M, Abd-Elkareem M, Mustafic M, Abdel-Maksoud M, Hakamy A, Baresova V PLoS One. 2024; 19(12):e0311760.

PMID: 39705219 PMC: 11661583. DOI: 10.1371/journal.pone.0311760.


To explore the protective mechanism of promethazine against hippocampal neuron injury based on network pharmacology and experimental verification.

Bai L, Li F Medicine (Baltimore). 2024; 103(49):e40550.

PMID: 39654167 PMC: 11631019. DOI: 10.1097/MD.0000000000040550.


Therapeutic approaches targeting aging and cellular senescence in Huntington's disease.

Bhat A, Moglad E, Afzal M, Thapa R, Almalki W, Kazmi I CNS Neurosci Ther. 2024; 30(10):e70053.

PMID: 39428700 PMC: 11491556. DOI: 10.1111/cns.70053.


References
1.
Budanov A, Sablina A, Feinstein E, Koonin E, Chumakov P . Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science. 2004; 304(5670):596-600. DOI: 10.1126/science.1095569. View

2.
Migliaccio E, Mele S, Salcini A, Pelicci G, Lai K, Superti-Furga G . Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J. 1997; 16(4):706-16. PMC: 1169672. DOI: 10.1093/emboj/16.4.706. View

3.
Matheu A, Maraver A, Klatt P, Flores I, Garcia-Cao I, Borras C . Delayed ageing through damage protection by the Arf/p53 pathway. Nature. 2007; 448(7151):375-9. DOI: 10.1038/nature05949. View

4.
Scolnick D, Chehab N, Stavridi E, LIEN M, Caruso L, Moran E . CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res. 1997; 57(17):3693-6. View

5.
Guarente L . Sir2 links chromatin silencing, metabolism, and aging. Genes Dev. 2000; 14(9):1021-6. View